Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Hepatocellular 8Neuroendocrine Tumors 2Neoplasm Metastasis 2Liver Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Cholangiocarcinoma 2Sarcoma 1Recurrence 1Rectal Neoplasms 1Ovarian Neoplasms 1Liver Malignancy 1Hepatic Malignancies 1Carcinoma, Ovarian Epithelial 1Bile Duct Neoplasms 1

Interventions

Oxaliplatin 112Fluorouracil 104Leucovorin 91Irinotecan 91Capecitabine 59Bevacizumab 58Cetuximab 46Folfox protocol 28Colonoscopy 24Panitumumab 19Chemotherapy, Adjuvant 19Blood Specimen Collection 19Drug Therapy 18Nivolumab 17Magnetic Resonance Spectroscopy 17Radiotherapy 16Exercise 16Early Intervention, Educational 16Surveys and Questionnaires 15Laparoscopy 15Surgical Procedures, Operative 13Floxuridine 13Biopsy 13trifluridine tipiracil drug combination 12pembrolizumab 12XELOX 12Neoadjuvant Therapy 11Methods 11Immunohistochemistry 11Celecoxib 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Colonic Neoplasms × Yttrium-90 × Clear all
NCT04108481 2025-03-28

iRE-C

University of Iowa

Phase 1 Terminated
5 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00766220 2013-01-03

Yttrium Microspheres With Cetuximab Plus Irinotecan for Patients With Advanced Colorectal Cancer Mets to Liver

M.D. Anderson Cancer Center

Phase 2 Withdrawn
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡